Form 4: Cryo-Cell International Inc. Executive Acquires Additional Stock Options
SEC Filing
Oleg Mikulinsky, Chief Information Officer of Cryo-Cell International Inc., reports acquisition of 10,000 stock options.
Summary
- Oleg Mikulinsky, Chief Information Officer of Cryo-Cell International Inc. (CCEL), filed a Form 4 detailing changes in beneficial ownership.
- The report indicates that Mr. Mikulinsky acquired 10,000 stock options on January 21, 2025, with an exercise price of $7.35.
- These options vest in three tranches: 1/3 upon issuance, 1/3 on January 21, 2026, and 1/3 on January 21, 2027.
- Mr. Mikulinsky directly owns 104,349 shares of common stock.
- He also holds various other stock options with different exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a routine disclosure of stock option grants. The acquisition of options by an executive is generally viewed as a positive sign, but it's not a major event.
Positives
- The acquisition of stock options by a company officer can be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The acquisition of stock options by a company officer can positively influence shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/21/2018 | Date of stock options with an expiration date of 05/21/2028. |
| 09/04/2019 | Date of stock options with an expiration date of 09/04/2029. |
| 02/27/2020 | Date of stock options with an expiration date of 02/27/2030. |
| 09/23/2021 | Date of stock options with an expiration date of 09/23/2028; vesting commences on this date. |
| 12/28/2021 | Date of stock options with an expiration date of 12/28/2028; options vest immediately if the stock price reaches $25.00. |
| 12/22/2023 | Date of stock options with an expiration date of 12/22/2028; vesting occurs in three tranches. |
| 01/21/2025 | Date of transaction and grant of 10,000 stock options; vesting occurs in three tranches. |
| 01/23/2025 | Date of filing. |
| 01/21/2026 | Second vesting date for the 10,000 stock options granted on 01/21/2025. |
| 01/21/2027 | Third vesting date for the 10,000 stock options granted on 01/21/2025. |
| 05/21/2028 | Expiration date of stock options. |
| 09/23/2028 | Expiration date of stock options. |
| 12/22/2028 | Expiration date of stock options. |
| 12/28/2028 | Expiration date of stock options. |
| 09/04/2029 | Expiration date of stock options. |
| 02/27/2030 | Expiration date of stock options. |
| 01/21/2030 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.